Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before.

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX ...

Healthcare giants AbbVie and Abbott Laboratories are both Dividend Kings. They should maintain their dividend growth habits ...

Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion July 02, 2025 — 10:01 am EDT Written by Zacks Equity Research for Zacks -> ...

The market increasingly favours closed-loop tech with extended sensor life, real-time glucose visibility and intelligent ...

Abbott’s ABT diversified business portfolio appears to be well-positioned to drive continued momentum in 2025. The stock carries a Zacks Rank #2 (Buy) currently. Factors Driving ABT Shares Within ...

Abbott's mixed reality technology helps distract blood donors and reduce their anxiety levels. This can help encourage young ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...

Abbott and Beta Bionics are collaborating to integrate Abbott’s upcoming dual glucose-ketone sensor with Beta’s iLet Bionic ...